Abiopharma

New Form 8-K - NATIONAL RESEARCH CORP Filed: 2025-07-28 AccNo: 0001437749-25-023676 Size: 446 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 4 - Zoetis Inc. Filed: 2025-07-28 AccNo: 0001555280-25-000253 Size: 10 KB

New Form DEF 14A - Vistagen Therapeutics, Inc. Filed: 2025-07-28 AccNo: 0001411685-25-000052 Size: 5 MB

New Form 144 - HEALTHCARE SERVICES GROUP INC Filed: 2025-07-28 AccNo: 0001950047-25-005231 Size: 8 KB

New Form S-1/A - Propanc Biopharma, Inc. Filed: 2025-07-28 AccNo: 0001641172-25-021182 Size: 20 MB

New Form 4 - GILEAD SCIENCES, INC. Filed: 2025-07-28 AccNo: 0001127602-25-019654 Size: 12 KB

New Form 8-K - Bluejay Diagnostics, Inc. Filed: 2025-07-28 AccNo: 0001213900-25-068296 Size: 252 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

New Form 4 - Medpace Holdings, Inc. Filed: 2025-07-28 AccNo: 0001668397-25-000093 Size: 8 KB

New Form 4 - DANAHER CORP /DE/ Filed: 2025-07-28 AccNo: 0000313616-25-000170 Size: 6 KB

New Form 4 - DANAHER CORP /DE/ Filed: 2025-07-28 AccNo: 0000313616-25-000168 Size: 6 KB